Ultra-Low-Dose Ketamine May Offer Relief For Opioid Withdrawal, Study Finds

A recent pilot study from the University of Washington School of Medicine shows a low dosage of ketamine can reduce or help eliminate withdrawal symptoms from fentanyl addiction.

Medical journal Addiction Science & Clinical Practice published the results Tuesday.

A 16-milligram dose of ketamine helped patients transition to buprenorphine treatment, a common opioid addiction therapy, researchers determined.

Study Scope And Findings

The research team, led by Dr. Lucinda Grande, administered ketamine to 37 patients over 14 months. Of the 24 patients who tried the treatment, 16 completed the transition to buprenorphine, with 92% of the last 12 remaining in treatment for at least 30 days. Patients reported a significant reduction in …

Full story available on Benzinga.com